Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

American Healthcare REIT share price today

American Healthcare REIT, Inc. · AHR · Real Estate · REIT - Healthcare Facilities · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

American Healthcare REIT share price: $56.37 at the close on 4 November 2026, +14.1% in a year.

$56.37Price +14.1% in a year
85.0×P/E lower than 60% of the last 1 year
$675 MRevenue (Jun 2026) +24.7% on a year ago
$30.6 MProfit (Jun 2026) +208.9% on a year ago
6.8%Operating margin −1.5 points on a year ago
2%ROE FY25

American Healthcare REIT, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high.

The price has been rising for 4 weeks, and the P/E is lower than 60% of its own last 1 year. Over the last four quarters, results have been improving, with profit +208.9% on a year earlier. What will decide it: the next one or two quarters of results.

What is the American Healthcare REIT share price today?

American Healthcare REIT, Inc.'s share price was $56.37 at the close on 4 November 2026. It has been rising for 4 weeks. That is 9.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $46 and $57, and at that close it sat 90% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today American Healthcare REIT, Inc. is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.

1Y

Nov 2026: $56.37, 9.3% above its 200-day average. The price has been rising for 4 weeks.

  • Price $56.37
  • 50-day avg $53.09
  • 200-day avg $51.58
Nov 2026: $56.37, 9.3% above its 200-day average. The price has been rising for 4 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$45.32$42.50$35.46
7 Nov 2025$49.42$42.97$35.93
14 Nov 2025$48.32$43.58$36.42
21 Nov 2025$48.00$44.17$36.92
28 Nov 2025$50.78$44.75$37.35
5 Dec 2025$50.11$45.56$37.91
12 Dec 2025$47.25$46.20$38.39
19 Dec 2025$48.13$46.89$38.83
26 Dec 2025$47.95$47.43$39.23
2 Jan 2026$47.24$47.81$39.59
9 Jan 2026$47.28$48.14$40.02
16 Jan 2026$48.01$48.38$40.46
23 Jan 2026$46.24$48.28$40.81
30 Jan 2026$46.91$48.10$41.25
6 Feb 2026$48.77$48.00$41.70
13 Feb 2026$51.80$48.08$42.19
20 Feb 2026$51.93$48.26$42.59
27 Feb 2026$52.24$48.76$43.07
6 Mar 2026$51.51$49.18$43.50
13 Mar 2026$52.16$49.61$43.95
20 Mar 2026$48.11$50.05$44.37
27 Mar 2026$47.13$50.08$44.69
2 Apr 2026$48.09$50.03$44.92
10 Apr 2026$49.23$50.24$45.23
17 Apr 2026$49.59$50.44$45.56
24 Apr 2026$50.10$50.44$45.89
1 May 2026$50.15$50.25$46.22
8 May 2026$51.71$50.01$46.53
15 May 2026$49.35$49.86$46.86
22 May 2026$50.19$49.68$47.14
29 May 2026$48.89$49.47$47.33
5 Jun 2026$47.48$49.28$47.49
12 Jun 2026$46.81$49.21$47.59
18 Jun 2026$46.52$49.11$47.67
26 Jun 2026$51.00$49.18$47.85
2 Jul 2026$55.04$49.43$48.05
10 Jul 2026$53.57$49.87$48.35
17 Jul 2026$57.16$50.39$48.68
24 Jul 2026$57.44$51.03$49.07
31 Jul 2026$55.60$51.65$49.48
7 Aug 2026$56.74$52.11$49.79
14 Aug 2026$54.31$52.71$50.05
21 Aug 2026$55.93$53.57$50.30
28 Aug 2026$55.53$54.56$50.52
4 Sep 2026$54.72$55.26$50.70
11 Sep 2026$53.58$55.40$50.80
18 Sep 2026$52.15$55.26$50.88
25 Sep 2026$52.02$54.99$50.93
2 Oct 2026$50.75$54.42$51.02
9 Oct 2026$50.80$53.74$51.08
16 Oct 2026$53.23$53.50$51.19
23 Oct 2026$53.02$53.40$51.34
30 Oct 2026$53.52$53.17$51.47
4 Nov 2026$56.37$53.09$51.58
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $56.37, 9.3% above its 200-day average. The price has been rising for 4 weeks.

  • Price $56.37
  • 50-day avg $53.09
  • 200-day avg $51.58
Nov 2026: $56.37, 9.3% above its 200-day average. The price has been rising for 4 weeks.
WeekPrice50-day avg200-day avg
9 Feb 2024$13.12––
16 Feb 2024$13.87––
23 Feb 2024$13.60––
1 Mar 2024$13.68––
8 Mar 2024$13.81––
15 Mar 2024$13.59––
22 Mar 2024$13.93––
28 Mar 2024$14.75––
5 Apr 2024$13.62––
12 Apr 2024$13.63––
19 Apr 2024$13.21$13.70–
26 Apr 2024$13.68$13.73–
3 May 2024$13.73$13.75–
10 May 2024$14.01$13.80–
17 May 2024$14.50$13.85–
24 May 2024$14.00$13.88–
31 May 2024$14.66$13.92–
7 Jun 2024$14.62$13.96–
14 Jun 2024$14.72$14.02–
21 Jun 2024$14.93$14.12–
28 Jun 2024$14.61$14.27–
5 Jul 2024$15.37$14.41–
12 Jul 2024$16.00$14.60–
19 Jul 2024$16.46$14.85–
26 Jul 2024$16.62$15.11–
2 Aug 2024$16.14$15.29–
9 Aug 2024$16.72$15.53–
16 Aug 2024$19.01$15.87–
23 Aug 2024$21.01$16.39–
30 Aug 2024$20.93$17.01–
6 Sep 2024$22.05$17.56–
13 Sep 2024$24.58$18.41–
20 Sep 2024$25.68$19.34–
27 Sep 2024$26.12$20.33–
4 Oct 2024$25.05$21.21–
11 Oct 2024$24.58$22.04–
18 Oct 2024$25.21$22.91–
25 Oct 2024$25.87$23.68–
1 Nov 2024$26.17$24.37–
8 Nov 2024$26.08$24.85–
15 Nov 2024$27.18$25.35–
22 Nov 2024$28.58$25.82$18.08
29 Nov 2024$29.81$26.20$18.40
6 Dec 2024$28.55$26.47$18.78
13 Dec 2024$28.47$26.73$19.14
20 Dec 2024$27.75$27.04$19.49
27 Dec 2024$28.48$27.32$19.79
3 Jan 2025$28.17$27.58$20.07
10 Jan 2025$27.22$27.73$20.35
17 Jan 2025$27.90$27.88$20.68
24 Jan 2025$28.90$28.09$20.97
31 Jan 2025$28.29$28.33$21.36
7 Feb 2025$29.30$28.43$21.76
14 Feb 2025$28.14$28.30$22.12
21 Feb 2025$27.31$28.22$22.39
28 Feb 2025$29.79$28.33$22.78
7 Mar 2025$28.91$28.54$23.17
14 Mar 2025$29.49$28.57$23.53
21 Mar 2025$29.61$28.75$23.92
28 Mar 2025$30.43$29.01$24.30
4 Apr 2025$28.50$29.19$24.68
11 Apr 2025$29.27$29.14$25.03
17 Apr 2025$30.61$29.26$25.34
25 Apr 2025$31.11$29.46$25.72
2 May 2025$32.55$29.86$26.12
9 May 2025$34.93$30.28$26.53
16 May 2025$35.51$30.76$26.99
23 May 2025$34.33$31.36$27.45
30 May 2025$34.94$31.77$27.81
6 Jun 2025$35.48$32.26$28.22
13 Jun 2025$35.40$32.77$28.60
20 Jun 2025$35.87$33.33$28.89
27 Jun 2025$36.07$34.01$29.25
3 Jul 2025$37.07$34.52$29.51
11 Jul 2025$36.65$35.03$29.80
18 Jul 2025$37.83$35.54$30.08
25 Jul 2025$37.35$35.94$30.39
1 Aug 2025$38.89$36.25$30.73
8 Aug 2025$40.51$36.80$31.10
15 Aug 2025$40.45$37.37$31.48
22 Aug 2025$42.47$38.00$31.86
29 Aug 2025$42.79$38.72$32.28
5 Sep 2025$42.73$39.20$32.60
12 Sep 2025$42.67$39.86$32.98
19 Sep 2025$42.22$40.46$33.31
26 Sep 2025$42.15$40.96$33.65
3 Oct 2025$40.90$41.33$33.98
10 Oct 2025$40.56$41.62$34.30
17 Oct 2025$43.39$41.88$34.65
24 Oct 2025$44.31$42.16$35.03
31 Oct 2025$45.32$42.50$35.46
7 Nov 2025$49.42$42.97$35.93
14 Nov 2025$48.32$43.58$36.42
21 Nov 2025$48.00$44.17$36.92
28 Nov 2025$50.78$44.75$37.35
5 Dec 2025$50.11$45.56$37.91
12 Dec 2025$47.25$46.20$38.39
19 Dec 2025$48.13$46.89$38.83
26 Dec 2025$47.95$47.43$39.23
2 Jan 2026$47.24$47.81$39.59
9 Jan 2026$47.28$48.14$40.02
16 Jan 2026$48.01$48.38$40.46
23 Jan 2026$46.24$48.28$40.81
30 Jan 2026$46.91$48.10$41.25
6 Feb 2026$48.77$48.00$41.70
13 Feb 2026$51.80$48.08$42.19
20 Feb 2026$51.93$48.26$42.59
27 Feb 2026$52.24$48.76$43.07
6 Mar 2026$51.51$49.18$43.50
13 Mar 2026$52.16$49.61$43.95
20 Mar 2026$48.11$50.05$44.37
27 Mar 2026$47.13$50.08$44.69
2 Apr 2026$48.09$50.03$44.92
10 Apr 2026$49.23$50.24$45.23
17 Apr 2026$49.59$50.44$45.56
24 Apr 2026$50.10$50.44$45.89
1 May 2026$50.15$50.25$46.22
8 May 2026$51.71$50.01$46.53
15 May 2026$49.35$49.86$46.86
22 May 2026$50.19$49.68$47.14
29 May 2026$48.89$49.47$47.33
5 Jun 2026$47.48$49.28$47.49
12 Jun 2026$46.81$49.21$47.59
18 Jun 2026$46.52$49.11$47.67
26 Jun 2026$51.00$49.18$47.85
2 Jul 2026$55.04$49.43$48.05
10 Jul 2026$53.57$49.87$48.35
17 Jul 2026$57.16$50.39$48.68
24 Jul 2026$57.44$51.03$49.07
31 Jul 2026$55.60$51.65$49.48
7 Aug 2026$56.74$52.11$49.79
14 Aug 2026$54.31$52.71$50.05
21 Aug 2026$55.93$53.57$50.30
28 Aug 2026$55.53$54.56$50.52
4 Sep 2026$54.72$55.26$50.70
11 Sep 2026$53.58$55.40$50.80
18 Sep 2026$52.15$55.26$50.88
25 Sep 2026$52.02$54.99$50.93
2 Oct 2026$50.75$54.42$51.02
9 Oct 2026$50.80$53.74$51.08
16 Oct 2026$53.23$53.50$51.19
23 Oct 2026$53.02$53.40$51.34
30 Oct 2026$53.52$53.17$51.47
4 Nov 2026$56.37$53.09$51.58
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

Price stage: Rising from Oct 2025 to May 2026; Sideways in Jun 2026; Rising from Jun 2026 to Nov 2026.

Price stage: Rising from Jun 2025 to May 2026; Sideways in Jun 2026; Rising from Jun 2026 to Nov 2026.

Week by week since 2024: did it beat the S&P 500 over the past 13 weeks?

Ahead in 110 of 131 weeks

Week by week since 2024: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
9 Feb 2024no S&P 500 reading
16 Feb 2024no S&P 500 reading
23 Feb 2024no S&P 500 reading
1 Mar 2024no S&P 500 reading
8 Mar 2024no S&P 500 reading
15 Mar 2024no S&P 500 reading
22 Mar 2024no S&P 500 reading
28 Mar 2024no S&P 500 reading
5 Apr 2024no S&P 500 reading
12 Apr 2024no S&P 500 reading
19 Apr 2024no S&P 500 reading
26 Apr 2024no S&P 500 reading
3 May 2024no S&P 500 reading
10 May 2024+2.9%
17 May 2024−1.5%
24 May 2024−1.3%
31 May 2024+4.3%
7 Jun 2024+1.5%
14 Jun 2024+1.9%
21 Jun 2024+2.7%
28 Jun 2024−5.0%
5 Jul 2024+5.9%
12 Jul 2024+7.8%
19 Jul 2024+13.7%
26 Jul 2024+14.4%
2 Aug 2024+13.3%
9 Aug 2024+17.0%
16 Aug 2024+26.4%
23 Aug 2024+43.9%
30 Aug 2024+35.9%
6 Sep 2024+49.6%
13 Sep 2024+63.4%
20 Sep 2024+67.6%
27 Sep 2024+73.8%
4 Oct 2024+59.7%
11 Oct 2024+50.1%
18 Oct 2024+46.7%
25 Oct 2024+49.3%
1 Nov 2024+55.0%
8 Nov 2024+43.7%
15 Nov 2024+37.3%
22 Nov 2024+30.1%
29 Nov 2024+35.5%
6 Dec 2024+17.0%
13 Dec 2024+8.3%
20 Dec 2024+4.0%
27 Dec 2024+4.9%
3 Jan 2025+9.1%
10 Jan 2025+10.6%
17 Jan 2025+8.4%
24 Jan 2025+6.7%
31 Jan 2025+2.7%
7 Feb 2025+11.9%
14 Feb 2025−0.6%
21 Feb 2025−5.2%
28 Feb 2025+1.3%
7 Mar 2025+6.5%
14 Mar 2025+10.4%
21 Mar 2025+11.3%
28 Mar 2025+13.5%
4 Apr 2025+15.8%
11 Apr 2025+15.6%
17 Apr 2025+21.6%
25 Apr 2025+17.1%
2 May 2025+20.9%
9 May 2025+25.3%
16 May 2025+28.7%
23 May 2025+29.2%
30 May 2025+18.1%
6 Jun 2025+18.7%
13 Jun 2025+14.0%
20 Jun 2025+15.8%
27 Jun 2025+7.9%
3 Jul 2025+6.3%
11 Jul 2025+8.4%
18 Jul 2025+4.4%
25 Jul 2025+4.4%
1 Aug 2025+9.8%
8 Aug 2025+3.1%
15 Aug 2025+5.6%
22 Aug 2025+12.3%
29 Aug 2025+13.0%
5 Sep 2025+12.4%
12 Sep 2025+10.4%
19 Sep 2025+6.0%
26 Sep 2025+9.2%
3 Oct 2025+3.3%
10 Oct 2025+6.0%
17 Oct 2025+8.8%
24 Oct 2025+12.3%
31 Oct 2025+6.8%
7 Nov 2025+16.7%
14 Nov 2025+15.0%
21 Nov 2025+10.9%
28 Nov 2025+12.7%
5 Dec 2025+11.3%
12 Dec 2025+7.0%
19 Dec 2025+11.5%
26 Dec 2025+9.5%
2 Jan 2026+13.4%
9 Jan 2026+10.3%
16 Jan 2026+6.5%
23 Jan 2026+2.6%
30 Jan 2026+2.1%
6 Feb 2026−4.2%
13 Feb 2026+5.7%
20 Feb 2026+3.6%
27 Feb 2026+2.5%
6 Mar 2026+4.7%
13 Mar 2026+13.2%
20 Mar 2026+4.7%
27 Mar 2026+6.4%
2 Apr 2026+5.8%
10 Apr 2026+6.2%
17 Apr 2026+0.6%
24 Apr 2026+4.8%
1 May 2026+2.8%
8 May 2026−0.8%
15 May 2026−13.2%
22 May 2026−11.5%
29 May 2026−16.7%
5 Jun 2026−17.5%
12 Jun 2026−22.3%
18 Jun 2026−18.4%
26 Jun 2026−6.8%
2 Jul 2026+0.9%
10 Jul 2026−2.3%
17 Jul 2026+10.6%
24 Jul 2026+11.2%
31 Jul 2026+7.2%
7 Aug 2026+4.9%
14 Aug 2026+5.0%
21 Aug 2026+8.7%
28 Aug 2026+11.9%
4 Sep 2026+10.8%
11 Sep 2026+11.4%
18 Sep 2026+10.1%
25 Sep 2026−3.8%
2 Oct 2026−11.1%
9 Oct 2026−8.3%
16 Oct 2026−9.6%
23 Oct 2026−10.5%
30 Oct 2026−4.9%
4 Nov 2026+0.2%
Each bar is one week, from 2024 to now (131 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 2.7 years the share price moved +330% while the S&P 500 moved +53%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does American Healthcare REIT pay?

American Healthcare REIT, Inc. paid $1.00 per share over the last four reported quarters. The most recent declaration was $0.25 for Jun 2026. At today's price of $56.37 that is a yield of 1.77%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.25 (Jun 2026)

  • Dividend per share $0.25
Dividend per share each quarter: latest $0.25 (Jun 2026)
QuarterDividend per share
Sep 2023$0.25
Dec 2023$0.25
Mar 2024$0.25
Jun 2024$0.25
Sep 2024$0.25
Dec 2024$0.25
Mar 2025$0.25
Jun 2025$0.25
Sep 2025$0.25
Dec 2025$0.25
Mar 2026$0.25
Jun 2026$0.25
Declared dividend per share, $ a share, each reported quarter. 12 quarters on file.

Which stock lists is American Healthcare REIT on?

American Healthcare REIT is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is American Healthcare REIT profitable?

American Healthcare REIT, Inc. earned $30.6 M of net profit in the Jun 2026 quarter, +208.9% on the same quarter a year earlier. Full-year FY25 profit was $69.8 M. That is 4.5% of the quarter's revenue. The same quarter a year earlier earned $9.9 M. 6 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

FY25 profit $69.8 M

  • Net profit $69.8 M
FY25 profit $69.8 M
QuarterNet profit
FY21−$47.8 M
FY22−$81.3 M
FY23−$71.5 M
FY24−$37.8 M
FY25$69.8 M
Net profit each year, $ M. 5-year window. A grey bar is lower than the year before.

Jun 2026: $30.6 M (+208.9% on a year earlier)

  • Net profit (quarterly) $30.6 M
Jun 2026: $30.6 M (+208.9% on a year earlier)
QuarterNet profit (quarterly)
Sep 2023−$6.0 M
Dec 2023−$27.4 M
Mar 2024−$3.9 M
Jun 2024$2.0 M
Sep 2024−$4.1 M
Dec 2024−$31.8 M
Mar 2025−$6.8 M
Jun 2025$9.9 M
Sep 2025$55.9 M
Dec 2025$10.8 M
Mar 2026$23.7 M
Jun 2026$30.6 M

Growth on a year earlier

  • Growth on a year earlier 208.9%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023–
Dec 2023–
Mar 2024–
Jun 2024–
Sep 2024–
Dec 2024–
Mar 2025–
Jun 2025400.7%
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026208.9%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

How much revenue does American Healthcare REIT make, and is it growing?

American Healthcare REIT, Inc. reported $675 M of revenue in the Jun 2026 quarter, +24.7% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 15.6% a year on average. The last full year, FY25, came in at $2.3 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $2.5 B.

FY25 revenue was $2.3 B, +9.4% on the year before.

FY25 revenue $2.3 B (+9.4% on the year before), 15.6% a year over 4 years

  • Revenue $2.3 B
FY25 revenue $2.3 B (+9.4% on the year before), 15.6% a year over 4 years
QuarterRevenue
FY21$1.3 B
FY22$1.6 B
FY23$1.9 B
FY24$2.1 B
FY25$2.3 B

Growth on a year earlier

  • Growth on a year earlier 9.4%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2228.1%
FY2315.2%
FY2410.7%
FY259.4%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $675 M (+24.7% on a year earlier), the 12th quarter in a row of growth

  • Revenue (quarterly) $675 M
Jun 2026: $675 M (+24.7% on a year earlier), the 12th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$463 M
Dec 2023$482 M
Mar 2024$498 M
Jun 2024$504 M
Sep 2024$522 M
Dec 2024$540 M
Mar 2025$539 M
Jun 2025$541 M
Sep 2025$573 M
Dec 2025$605 M
Mar 2026$652 M
Jun 2026$675 M

Growth on a year earlier

  • Growth on a year earlier 24.7%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 202310.3%
Dec 20237.2%
Mar 202410.3%
Jun 20249.2%
Sep 202412.8%
Dec 202412.1%
Mar 20258.1%
Jun 20257.5%
Sep 20259.9%
Dec 202511.9%
Mar 202620.9%
Jun 202624.7%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +16.9% on average, against 15.6% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +16.9%, against +13.4% a year over the last 8 quarters (accelerating).

How much of every $100 of sales does American Healthcare REIT keep?

American Healthcare REIT, Inc.'s operating margin was 6.8% in the Jun 2026 quarter, 1.5 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 0.4% and 7.4%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Across 5 years it has been between 0.4% and 7.4%, and FY25's 7.4% is the highest of them.

Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead.

FY25: 7.4%, the highest in a range of 0.4% to 7.4% over 5 years

  • Operating margin 7.4%
FY25: 7.4%, the highest in a range of 0.4% to 7.4% over 5 years
QuarterOperating margin
FY210.4%
FY223.9%
FY234%
FY246.3%
FY257.4%

Change on the year before (points)

  • Change on the year before (points) +1.1 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22+3.5 pts
FY23+0.1 pts
FY24+2.3 pts
FY25+1.1 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 6.8% (−1.5 points on a year earlier)

  • Operating margin 6.8%
Jun 2026: operating margin 6.8% (−1.5 points on a year earlier)
QuarterOperating margin
Sep 20232.6%
Dec 20235.2%
Mar 20245.3%
Jun 20246.1%
Sep 20246.8%
Dec 20247%
Mar 20257.1%
Jun 20258.3%
Sep 20257.5%
Dec 20256.7%
Mar 20266.4%
Jun 20266.8%

Change on a year earlier (points)

  • Change on a year earlier (points) −1.5 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023−1.4 pts
Dec 2023+2.0 pts
Mar 2024+3.3 pts
Jun 2024+2.3 pts
Sep 2024+4.2 pts
Dec 2024+1.8 pts
Mar 2025+1.8 pts
Jun 2025+2.2 pts
Sep 2025+0.7 pts
Dec 2025−0.3 pts
Mar 2026−0.7 pts
Jun 2026−1.5 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is American Healthcare REIT's profit turning into cash?

American Healthcare REIT, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 it brought in $294 M of operating cash against $69.8 M of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $294 M against profit $69.8 M

  • Operating cash $294 M
  • Net profit $69.8 M
FY25: operating cash $294 M against profit $69.8 M
QuarterOperating cashNet profit
FY21$17.9 M−$47.8 M
FY22$148 M−$81.3 M
FY23$98.5 M−$71.5 M
FY24$176 M−$37.8 M
FY25$294 M$69.8 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $119 M = 388% of the quarter's profit

  • Operating cash (quarterly) $119 M
Jun 2026: operating cash $119 M = 388% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$29.1 M
Dec 2023$25.8 M
Mar 2024−$6.0 M
Jun 2024$59.4 M
Sep 2024$63.1 M
Dec 2024$59.5 M
Mar 2025$60.6 M
Jun 2025$71.5 M
Sep 2025$107 M
Dec 2025$55.2 M
Mar 2026$81.1 M
Jun 2026$119 M

Operating cash as % of profit

  • Operating cash as % of profit 388%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023–
Dec 2023–
Mar 2024–
Jun 20243,002%
Sep 2024–
Dec 2024–
Mar 2025–
Jun 2025721%
Sep 2025192%
Dec 2025512%
Mar 2026342%
Jun 2026388%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Where does American Healthcare REIT's cash go?

American Healthcare REIT, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

What is American Healthcare REIT's P/E ratio, and how does it compare with its own history?

American Healthcare REIT, Inc.'s P/E is 85.0×, in the middle of its own history: higher than 40% of past readings. Its usual P/E (the middle reading) is 86.8×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks.

P/E 85.0× against a usual 86.8×: in the middle of its own history: higher than 40% of past readings

  • P/E 83.5×
  • Median 86.8×
P/E 85.0× against a usual 86.8×: in the middle of its own history: higher than 40% of past readings
WeekP/EMedian
3 Oct 2025260.4×86.8×
10 Oct 2025260.4×86.8×
17 Oct 2025260.4×86.8×
24 Oct 2025260.4×86.8×
31 Oct 2025260.4×86.8×
7 Nov 2025260.4×86.8×
14 Nov 2025260.4×86.8×
21 Nov 2025260.4×86.8×
28 Nov 2025260.4×86.8×
5 Dec 2025260.4×86.8×
12 Dec 2025260.4×86.8×
19 Dec 2025260.4×86.8×
26 Dec 2025260.4×86.8×
2 Jan 2026115.8×86.8×
9 Jan 2026115.9×86.8×
16 Jan 2026117.7×86.8×
23 Jan 2026113.3×86.8×
30 Jan 2026115.0×86.8×
6 Feb 2026119.5×86.8×
13 Feb 2026127.0×86.8×
20 Feb 2026127.3×86.8×
27 Feb 2026128.0×86.8×
6 Mar 2026126.3×86.8×
13 Mar 2026127.8×86.8×
20 Mar 2026117.9×86.8×
27 Mar 2026115.5×86.8×
2 Apr 202683.2×86.8×
10 Apr 202685.2×86.8×
17 Apr 202685.8×86.8×
24 Apr 202686.7×86.8×
1 May 202686.8×86.8×
8 May 202689.5×86.8×
15 May 202685.4×86.8×
22 May 202686.8×86.8×
29 May 202684.6×86.8×
5 Jun 202682.2×86.8×
12 Jun 202681.0×86.8×
18 Jun 202680.5×86.8×
26 Jun 202688.2×86.8×
2 Jul 202681.5×86.8×
10 Jul 202679.4×86.8×
17 Jul 202684.7×86.8×
24 Jul 202685.1×86.8×
31 Jul 202682.4×86.8×
7 Aug 202684.1×86.8×
14 Aug 202680.5×86.8×
21 Aug 202682.9×86.8×
28 Aug 202682.3×86.8×
4 Sep 202681.1×86.8×
11 Sep 202679.4×86.8×
18 Sep 202677.3×86.8×
25 Sep 202677.1×86.8×
2 Oct 202675.2×86.8×
9 Oct 202675.3×86.8×
16 Oct 202678.9×86.8×
23 Oct 202678.5×86.8×
30 Oct 202679.3×86.8×
4 Nov 202683.5×86.8×

Earnings per share, 12 months

  • Earnings per share, 12 months $0.68
Earnings per share, 12 months
WeekEarnings per share, 12 months
3 Oct 2025–
10 Oct 2025–
17 Oct 2025–
24 Oct 2025–
31 Oct 2025–
7 Nov 2025–
14 Nov 2025–
21 Nov 2025–
28 Nov 2025–
5 Dec 2025–
12 Dec 2025–
19 Dec 2025–
26 Dec 2025$0.14
2 Jan 2026$0.14
9 Jan 2026$0.14
16 Jan 2026$0.14
23 Jan 2026$0.14
30 Jan 2026$0.14
6 Feb 2026$0.14
13 Feb 2026$0.14
20 Feb 2026$0.14
27 Feb 2026$0.14
6 Mar 2026$0.14
13 Mar 2026$0.14
20 Mar 2026$0.14
27 Mar 2026$0.41
2 Apr 2026$0.41
10 Apr 2026$0.41
17 Apr 2026$0.41
24 Apr 2026$0.41
1 May 2026$0.41
8 May 2026$0.41
15 May 2026$0.41
22 May 2026$0.41
29 May 2026$0.41
5 Jun 2026$0.41
12 Jun 2026$0.41
18 Jun 2026$0.41
26 Jun 2026$0.58
2 Jul 2026$0.58
10 Jul 2026$0.58
17 Jul 2026$0.58
24 Jul 2026$0.58
31 Jul 2026$0.58
7 Aug 2026$0.58
14 Aug 2026$0.58
21 Aug 2026$0.58
28 Aug 2026$0.58
4 Sep 2026$0.58
11 Sep 2026$0.58
18 Sep 2026$0.58
25 Sep 2026$0.68
2 Oct 2026$0.68
9 Oct 2026$0.68
16 Oct 2026$0.68
23 Oct 2026$0.68
30 Oct 2026$0.68
4 Nov 2026$0.68
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 1 year of history; short peaks above 260× are drawn at the top edge.
85.0×P/E · lower than 60% of its last 1 year
5.67PEG · today, as reported

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

Is the American Healthcare REIT business getting better or worse?

American Healthcare REIT, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +9.4% in FY25

  • Revenue growth 9.4%
Growth year by year: revenue +9.4% in FY25
QuarterRevenue growth
FY21–
FY2228.1%
FY2315.2%
FY2410.7%
FY259.4%
Growth on the year before, each year, %. Top: revenue. Zero line drawn.

Three growth lines over twelve quarters: revenue accelerating

  • Revenue 16.9%
Three growth lines over twelve quarters: revenue accelerating
QuarterRevenue
Sep 202319.3%
Dec 202314.7%
Mar 202412.1%
Jun 20249.2%
Sep 20249.9%
Dec 202411.1%
Mar 202510.5%
Jun 202510.1%
Sep 20259.4%
Dec 20259.4%
Mar 202612.7%
Jun 202616.9%

Profit

  • Profit 208.9%
Profit
QuarterProfit
Sep 2023–
Dec 2023–
Mar 2024–
Jun 2024–
Sep 2024–
Dec 2024–
Mar 2025–
Jun 2025300%
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026208.9%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Where the 12-month history is short, the line uses single-quarter growth instead, which is noisier; extreme jumps from a tiny base are evened out before reading. Extreme jumps from a tiny base are drawn at the edge (▲). A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 11.2%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 2023–
Dec 20236%
Mar 20247.7%
Jun 20249%
Sep 202411.2%
Dec 2024–
Mar 2025–
Jun 2025–
Sep 2025–
Dec 2025–
Mar 2026–
Jun 2026–
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +16.9%, range +9.2% to +19.3%
RisingROCE · latest 11.2%, range 6.0% to 11.2%

Why it matters: with too little history, we say so rather than guess a direction.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+9.4%+11.7%——
Stock price+14.1%———
+24.7%Revenue growth (Jun 2026) · latest quarter against a year ago
+208.9%Profit growth (Jun 2026) · latest quarter against a year ago
15.6%Revenue, 4 years · yearly growth over the long run

How much does American Healthcare REIT earn on its capital?

American Healthcare REIT, Inc. earned a ROE of 2% in FY25. That is up from a low of −5% in FY22. Its return on capital used (ROIC) is 4.8 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

It comes from a 3.1% net margin and 0.42× asset turnover (sales divided by assets).

Why the return is what it is (FY25): a 3.1% net margin × 0.42× asset turnover × 1.61× leverage (assets divided by equity) ≈ 2.1% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 3.3% − 8.1% = −4.8 percentage points. The 8.1% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

FY25: ROE 2%, the climb back from FY22's −5%

  • ROE 2.1%
  • ROIC (annual) 3.6%
  • Cost of capital 8.1%
FY25: ROE 2%, the climb back from FY22's −5%
QuarterROEROIC (annual)Cost of capital
FY21−2.6%0.2%8.1%
FY22−4.9%1.4%8.1%
FY23−4.9%1.7%8.1%
FY24−1.6%3.1%8.1%
FY252.1%3.6%8.1%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 8.1% cost of capital used on this page.

Jun 2026: ROIC 3.7% (last 12 months) against a 8.1% cost of capital

  • ROIC (12 months) 3.7%
  • ROE (12 months) 2.8%
  • Cost of capital 8.1%
Jun 2026: ROIC 3.7% (last 12 months) against a 8.1% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20231.3%−3%8.1%
Dec 20231.2%−1.7%8.1%
Mar 20241.5%−8.3%8.1%
Jun 20241.9%−0.7%8.1%
Sep 20242.1%0.6%8.1%
Dec 20242.6%−0.6%8.1%
Mar 20252.9%−5.7%8.1%
Jun 20253.2%−1.2%8.1%
Sep 20253.6%1.7%8.1%
Dec 20253.8%8.7%8.1%
Mar 20263.8%1.4%8.1%
Jun 20263.7%2.8%8.1%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does American Healthcare REIT have too much debt?

American Healthcare REIT, Inc. has total debt of $1.6 B against shareholder equity of $3.7 B as of Jun 2026, so its debt is 0.42× its equity. Year by year, that ratio went from 1.37 in FY21 to 0.50 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $1.7 B, 0.50× equity

  • Total debt $1.7 B
FY25: debt $1.7 B, 0.50× equity
QuarterTotal debt
FY21$2.5 B
FY22$2.8 B
FY23$2.8 B
FY24$1.9 B
FY25$1.7 B

Debt-to-equity

  • Debt-to-equity 0.50×
Debt-to-equity
QuarterDebt-to-equity
FY211.37×
FY221.72×
FY231.92×
FY240.81×
FY250.50×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $1.6 B, debt-to-equity 0.42

  • Total debt (quarterly) $1.6 B
Jun 2026: debt $1.6 B, debt-to-equity 0.42
QuarterTotal debt (quarterly)
Sep 2023$2.8 B
Dec 2023$2.8 B
Mar 2024$2.2 B
Jun 2024$2.2 B
Sep 2024$2.1 B
Dec 2024$1.9 B
Mar 2025$1.8 B
Jun 2025$1.7 B
Sep 2025$1.7 B
Dec 2025$1.7 B
Mar 2026$1.7 B
Jun 2026$1.6 B

Debt-to-equity

  • Debt-to-equity 0.42×
Debt-to-equity
QuarterDebt-to-equity
Sep 20231.80×
Dec 20231.92×
Mar 20241.05×
Jun 20241.06×
Sep 20240.93×
Dec 20240.81×
Mar 20250.80×
Jun 20250.70×
Sep 20250.62×
Dec 20250.50×
Mar 20260.48×
Jun 20260.42×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the American Healthcare REIT shareholding pattern?

14.4% of American Healthcare REIT, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 9.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

14.4%Short interest · of the tradable float
9.7Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is American Healthcare REIT from balance-sheet trouble?

For American Healthcare REIT, Inc., the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

How does American Healthcare REIT rank in its industry?

49.1 out of 100, rank 9 of 17 in REIT - Healthcare Facilities, with 67% of the evidence available.

American Healthcare REIT, Inc. scores 49.1 out of 100 against the 17 companies it is compared with in REIT - Healthcare Facilities, ranking 9. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 17.9 + 10.4 + 3.8 + 17 = 49.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector.

Which companies is American Healthcare REIT compared with?

American Healthcare REIT ranks 9 of 17 REIT - Healthcare Facilities companies on the 4-Factor Sector Score, with 49.1 out of 100.

  1. 1LTC Properties, Inc.LTC · leader · Most evidence points up · 76% evidence72.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.3/35 · Income 61% · Profit 61.5% · 71% evidenceCapital efficiency 15.9/25 · ROA 4.2% · ROE 8.5% · GNPA — · 68% evidenceValuation 12.3/20 · P/BV 1.47× · P/BV÷ROE 0.17 · 70% evidenceRelative strength 20.0/20 · Lead over its industry 20.2% · Lead over S&P 500 11.7% · 1 year 29.1% · 100% evidence · 9 of 12 weeks aheadExact sum: 24.3 + 15.9 + 12.3 + 20 = 72.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Omega Healthcare Investors, Inc.OHI · turning · Most evidence points up · 76% evidence70.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.1/35 · Income 13.1% · Profit 84.7% · 71% evidenceCapital efficiency 18.9/25 · ROA 5.1% · ROE 11.6% · GNPA — · 68% evidenceValuation 9.5/20 · P/BV 2.52× · P/BV÷ROE 0.22 · 70% evidenceRelative strength 15.7/20 · Lead over its industry 7.1% · Lead over S&P 500 -0.7% · 1 year 12.9% · 100% evidence · 0 of 12 weeks aheadExact sum: 26.1 + 18.9 + 9.5 + 15.7 = 70.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  3. 3Strawberry Fields REIT, Inc.STRW · quiet · Evidence leans up · 76% evidence64.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.4/35 · Income 19.4% · Profit 33.3% · 71% evidenceCapital efficiency 20.1/25 · ROA 6.3% · ROE 74.9% · GNPA — · 68% evidenceValuation 15.0/20 · P/BV 5.66× · P/BV÷ROE 0.08 · 70% evidenceRelative strength 7.2/20 · Lead over its industry 0.3% · Lead over S&P 500 -6.9% · 1 year 12.3% · 100% evidence · 0 of 12 weeks aheadExact sum: 22.4 + 20.1 + 15 + 7.2 = 64.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Healthpeak Properties, Inc.DOC · quiet · Evidence leans up · 76% evidence56.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 16.6/35 · Income 5.5% · Profit 42.5% · 71% evidenceCapital efficiency 11.8/25 · ROA 1.1% · ROE 9.2% · GNPA — · 68% evidenceValuation 12.7/20 · P/BV 1.55× · P/BV÷ROE 0.17 · 70% evidenceRelative strength 15.3/20 · Lead over its industry 8.8% · Lead over S&P 500 1.1% · 1 year 13.2% · 100% evidence · 2 of 12 weeks aheadExact sum: 16.6 + 11.8 + 12.7 + 15.3 = 56.4 · What this means: Relative strength against the index is 1.1%, and revenue and profit growth are weak.
  5. 5Welltower Inc.WELL · turning · Evidence leans up · 80% evidence53.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.2/35 · Income 39.2% · Profit 73.5% · 81% evidenceCapital efficiency 8.9/25 · ROA 0.9% · ROE 3.9% · GNPA — · 68% evidenceValuation 3.9/20 · P/BV 3.33× · P/BV÷ROE 0.85 · 70% evidenceRelative strength 18.6/20 · Lead over its industry 16.9% · Lead over S&P 500 8.5% · 1 year 30.3% · 100% evidence · 6 of 12 weeks aheadExact sum: 22.2 + 8.9 + 3.9 + 18.6 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6National Health Investors, Inc.NHI · basing · Evidence leans up · 76% evidence53.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.5/35 · Income 23.7% · Profit 16.2% · 71% evidenceCapital efficiency 18.0/25 · ROA 4.6% · ROE 10.3% · GNPA — · 68% evidenceValuation 9.0/20 · P/BV 2.33× · P/BV÷ROE 0.23 · 70% evidenceRelative strength 6.5/20 · Lead over its industry -6.1% · Lead over S&P 500 -13.2% · 1 year -7.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 19.5 + 18 + 9 + 6.5 = 53 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7CareTrust REIT, Inc.CTRE · basing · Evidence leans up · 76% evidence51.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.6/35 · Income 53.1% · Profit 62.6% · 71% evidenceCapital efficiency 15.8/25 · ROA 4.5% · ROE 7.7% · GNPA — · 68% evidenceValuation 7.6/20 · P/BV 2.11× · P/BV÷ROE 0.27 · 70% evidenceRelative strength 6.7/20 · Lead over its industry -0.6% · Lead over S&P 500 -7.9% · 1 year 5% · 100% evidence · 0 of 12 weeks aheadExact sum: 21.6 + 15.8 + 7.6 + 6.7 = 51.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Sabra Health Care REIT, Inc.SBRA · turning · Evidence leans down · 76% evidence49.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 13.3/35 · Income 17.7% · Profit -63.9% · 71% evidenceCapital efficiency 13.4/25 · ROA 3.2% · ROE 5.8% · GNPA — · 68% evidenceValuation 6.8/20 · P/BV 1.79× · P/BV÷ROE 0.31 · 70% evidenceRelative strength 16.1/20 · Lead over its industry 7.5% · Lead over S&P 500 -0.3% · 1 year 11.7% · 100% evidence · 3 of 12 weeks aheadExact sum: 13.3 + 13.4 + 6.8 + 16.1 = 49.6 · What this means: Relative strength against the index is -0.3%, and revenue and profit growth are weak.
  9. 9American Healthcare REIT, Inc. this pageAHR · turning · Evidence leans down · 67% evidence49.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.9/35 · Income 16.9% · Profit — · 45% evidenceCapital efficiency 10.4/25 · ROA 1.9% · ROE 2.8% · GNPA — · 68% evidenceValuation 3.8/20 · P/BV 2.69× · P/BV÷ROE 0.96 · 70% evidenceRelative strength 17.0/20 · Lead over its industry 11.8% · Lead over S&P 500 3.8% · 1 year 14.1% · 100% evidence · 5 of 12 weeks aheadExact sum: 17.9 + 10.4 + 3.8 + 17 = 49.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Ventas, Inc.VTR · quiet · Evidence leans down · 76% evidence47.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.3/35 · Income 21.6% · Profit 37.2% · 71% evidenceCapital efficiency 10.7/25 · ROA 2.1% · ROE 1.8% · GNPA — · 68% evidenceValuation 3.4/20 · P/BV 2.84× · P/BV÷ROE 1.58 · 70% evidenceRelative strength 11.7/20 · Lead over its industry 5.8% · Lead over S&P 500 -1.9% · 1 year 17.2% · 100% evidence · 2 of 12 weeks aheadExact sum: 21.3 + 10.7 + 3.4 + 11.7 = 47.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11Healthcare Realty Trust IncorporatedHR · basing · Too little evidence to rank firmly · 55% evidence46.9out of 100GrowthCapitalValuationRelative
  12. 12Universal Health Realty Income TrustUHT · basing · Evidence leans down · 76% evidence43.2out of 100GrowthCapitalValuationRelative
  13. 13Medical Properties Trust, Inc.MPT · quiet · Evidence leans down · 67% evidence42.5out of 100GrowthCapitalValuationRelative
  14. 14Community Healthcare Trust IncorporatedCHCT · basing · Evidence leans down · 67% evidence39.4out of 100GrowthCapitalValuationRelative
  15. 15Diversified Healthcare TrustDHC · quiet · Too little evidence to rank firmly · 55% evidence32.6out of 100GrowthCapitalValuationRelative
  16. 16Chiron Real Estate Inc.XRN · quiet · Most evidence points down · 67% evidence30.9out of 100GrowthCapitalValuationRelative
  17. 17Sila Realty Trust, Inc.SILA · Too little evidence to rank firmly · 43% evidence40.2out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: REIT - Healthcare Facilities, all 17 compared on one page.

Which companies are close to American Healthcare REIT in size?

American Healthcare REIT is the 5th largest of 17 REIT - Healthcare Facilities companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Ventas, Inc., Omega Healthcare Investors, Inc. and Healthpeak Properties, Inc. Just below it: CareTrust REIT, Inc., Healthcare Realty Trust Incorporated and Sabra Health Care REIT, Inc.

REIT - Healthcare Facilities companies close in size

  1. Ventas, Inc. $47.5 billion
  2. Omega Healthcare Investors, Inc. $15.6 billion
  3. Healthpeak Properties, Inc. $14.2 billion
  4. American Healthcare REIT, Inc. $13.1 billion
  5. CareTrust REIT, Inc. $9 billion
  6. Healthcare Realty Trust Incorporated $6.7 billion
  7. Sabra Health Care REIT, Inc. $5.5 billion

All 17 REIT - Healthcare Facilities companies, largest first

Companies close in size in other industries

  1. Equinox Gold Corp. $13.2 billion · Gold
  2. MKS Inc. $13.2 billion · Scientific & Technical Instruments
  3. American Healthcare REIT, Inc. $13.1 billion
  4. QXO, Inc. $13.1 billion · Industrial Distribution
  5. DICK'S Sporting Goods, Inc. $13.1 billion · Specialty Retail

What else do people ask about American Healthcare REIT?

What were American Healthcare REIT's latest quarterly results?

American Healthcare REIT, Inc. reported revenue of $675 M and net profit of $30.6 M for the Jun 2026 quarter. Revenue rose 24.7% and profit rose 208.9% compared with a year earlier. Earnings per share were $0.16.

The operating margin was 6.8%, 1.5 percentage points lower than a year earlier (as of 4 November 2026).

What is American Healthcare REIT's market cap?

American Healthcare REIT, Inc.'s market capitalisation is $13.1 B at a stock price of $56.37. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is American Healthcare REIT performing?

American Healthcare REIT, Inc.'s share price has been rising for 4 weeks. In its latest quarter, revenue rose 24.7% and profit rose 208.9% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 4 November 2026).

Will American Healthcare REIT's stock price go up?

This page does not forecast American Healthcare REIT, Inc.'s stock price. What it shows instead: the stock price is $56.37, and it has been rising for 4 weeks. Its P/E of 85.0× is higher than 40% of its own last 1 years (as of 4 November 2026).

Where is American Healthcare REIT in its business cycle?

American Healthcare REIT, Inc.'s FY25 operating margin was 7.4%, against a 5-year range of 0.4% to 7.4%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 6.8%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the American Healthcare REIT story?

Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is American Healthcare REIT a stock worth studying right now?

What the numbers show: American Healthcare REIT, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.